A carregar...
Publicação
Investment committee paper: Gerresheimer Ag - valuation
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.33 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
Gerresheimer is a leading medical device and packaging manufacturer for the
pharma, cosmetics, and food & beverage sectors, and poses a unique investment
opportunity. Gerresheimer operates a sophisticated procurement network that can
be leveraged to perform a strategic shift towards the MedTech industry. This can
be accomplished by carving-out its capex-heavy moulded glass division and using
the proceeds to acquire leading players in this industry, namely Ypsomed and H&T
Presspart, to also strengthen its recently established internal MedTech segment.
This strategy is expected to realize a return of 3.8x (30.5% IRR), whereby the exit
is likely to be a trade sale.
Descrição
Palavras-chave
Gerresheimer Lbo Buy-and build Carve-out Valuation